Related Experiment Video
Updated: Jun 20, 2026

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
Serologic evidence of frequent human infection with WU and KI polyomaviruses
Nang L Nguyen1, Binh Minh Le, David Wang
1Washington University in St. Louis, Missouri 63110, USA.
Abstract:
WU polyomavirus (WUPyV) and KI polyomavirus (KIPyV) are novel human polyomaviruses. They were originally identified in human respiratory secretions, but the extent of human infection caused by these viruses has not been described to date. To determine the seroepidemiology of WUPyV and KIpyIV, we used an ELISA to screen serum samples from 419 patients at the St. Louis Children's Hospital and Barnes-Jewish Hospital during 2007-2008. The age-stratified deidentified samples were examined for antibodies to the major capsid proteins of WUPyV and KIPyV. Seropositivity for each virus was similar; antibody levels were high in the youngest age group (<6 months), decreased to a nadir in the next age group (6 to <12 months), and then steadily increased with subsequent age groups, eventually reaching a plateau of approximate, equals 80% for WUPyV and approximate, equals 70% for KIPyV. These results demonstrate that both KIPyV and WUPyV cause widespread infection in the human population.
Insights
Novel human polyomaviruses, WU polyomavirus (WUPyV) and KI polyomavirus (KIPyV), cause widespread infections. Antibody levels indicate infection is common across all age groups, demonstrating broad population exposure.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- WU polyomavirus (WUPyV) and KI polyomavirus (KIPyV) are newly identified human polyomaviruses.
- Initial identification was in respiratory secretions, but their epidemiological extent remains unknown.
Purpose of the Study:
- To determine the seroepidemiology of WUPyV and KIPyV infections.
- To assess the prevalence of antibodies against these novel polyomaviruses in the human population.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to screen 419 serum samples.
- Samples were collected from patients at St. Louis Children's Hospital and Barnes-Jewish Hospital (2007-2008).
- Age-stratified, deidentified samples were tested for antibodies to WUPyV and KIPyV major capsid proteins.
Main Results:
- Seropositivity rates for WUPyV and KIPyV were comparable.
- Antibody levels were highest in infants under 6 months, decreased between 6-12 months, then steadily increased with age.
- Prevalence reached approximately 80% for WUPyV and 70% for KIPyV in older age groups.
Conclusions:
- Both KIPyV and WUPyV cause widespread infections in the human population.
- The study demonstrates significant seroprevalence across diverse age groups, indicating common exposure.
Related Concept Videos
Poliomyelitis
Cytomegalovirus Disease
Viral Recombination

